000			02006nam a2200361Ia 4500
001			ocm51932040
003			OCoLC
005			20180312141842.0
007			he bmb024bbca
008			030327s2002 dcu bb f000 0 eng d
040			_aFPS _beng _cFPS _dOCLCQ _dFCMBL _dOCLCF _dOCLCO _dOCLCQ. _dOCLCO _dOCLCQ _dGPO _dMvI
043			_an-us---
074			_a1019-B-01 (MF)
088			_aSerial no. 107-135 (United States. Congress. House. Committee on Energy and Commerce)
086	0		_aY 4.C 73/8:107-135
099			_aY 4.C 73/8:107-135
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Health.
245	1	0	_aExamining prescription drug importation : _ba review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
260			_aWashington : _bU.S. G.P.O. : _bFor sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], _c2002.
300			_aiii, 112 pages ; _c24 cm
336			_atext _btxt _2rdacontent
337			_amicroform _bh _2rdamedia
338			_amicrofiche _bhe _2rdacarrier
504			_aIncludes bibliographical references.
500			_a"Serial No. 107-135."
500			_aShipping list no.:2003-0144-M.
500			_aCRDP Program record.
533			_aMicrofiche. _bWashington : _cSupt. of Docs., U.S. G.P.O., _d2003. _e2 microfiches : negative.
650		0	_aPharmaceutical policy _zUnited States.
650		0	_aPrescription pricing _zUnited States.
650		0	_aDrugs _xLaw and legislation _zUnited States.
776	0	8	_iOnline version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. _tExamining prescription drug importation _w(OCoLC)852783757
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. _tExamining prescription drug importation _w(OCoLC)51390149
999			_c269567 _d269567